Effect of inflammation on voriconazole levels in patients with invasive pulmonary aspergillosis
Patients diagnosed with CAPA were more prone to adverse effects and supra-therapeutic VCZ levels. More frequent therapeutic drug monitoring is recommended in this patient population.
Authors
- Emre Kara (ORCID: https://orcid.org/0000-0002-7034-4787)
- Pınar Bakır Ekinci (ORCID: https://orcid.org/0000-0003-0694-6078)
- Ömrüm Uzun (ORCID: https://orcid.org/0000-0003-4721-0139)
- Kutay Demirkan (ORCID: https://orcid.org/0000-0002-6427-5826)
- Ahmet Çağkan İnkaya (ORCID: https://orcid.org/0000-0001-7943-8715)
- Aslı Pinar (ORCID: https://orcid.org/0000-0002-4433-1210)
- Gökhan Metan (ORCID: https://orcid.org/0000-0002-2676-4557)
- Ahmet Görkem Er (ORCID: https://orcid.org/0000-0001-6638-7955)
Institutions
- Hacettepe University (TR)
Publication Details
- Journal
- The Journal of Infection in Developing Countries
- Published
- 2024-10-31
- DOI
- https://doi.org/10.3855/jidc.19290
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 0.00